I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Gonzalez-Fierro, Aurora
312
results:
Articles (Online) X
Search for persons
X
Languages
english (263)
spanish (4)
Sorted by: Relevance
Sorted by: Year
?
1
Does Therapeutic Repurposing in Cancer Meet the Expectation..:
Gonzalez-Fierro, Aurora
;
Romo-Pérez, Adriana
;
Chávez-Blanco, Alma
..
Clinical Drug Investigation. 43 (2023) 4 - p. 227-239 , 2023
Link:
https://doi.org/10.1007/..
?
2
Selection of clinically relevant drug concentrations for in..:
Robles-Bañuelos, Benjamin
;
Romo-Perez, Adriana
;
Dominguez-Gomez, Guadalupe
...
Clinical and Translational Oncology. 26 (2023) 5 - p. 1077-1088 , 2023
Link:
https://doi.org/10.1007/..
?
3
Drug repurposing for cancer therapy, easier said than done:
Gonzalez-Fierro, Aurora
;
Dueñas-González, Alfonso
Seminars in Cancer Biology. 68 (2021) - p. 123-131 , 2021
Link:
https://doi.org/10.1016/..
?
4
Barriers for Pharmaceutical Innovation With Focus in Cancer..:
Duenas-Gonzalez, Alfonso
;
Gonzalez-Fierro, Aurora
Therapeutic Innovation & Regulatory Science. 54 (2020) 2 - p. 342-352 , 2020
Link:
https://doi.org/10.1007/..
?
5
Barriers for Pharmaceutical Innovation With Focus in Cancer..:
Duenas-Gonzalez, Alfonso
;
Gonzalez-Fierro, Aurora
Therapeutic Innovation & Regulatory Science. , 2019
Link:
https://doi.org/10.1177/..
?
6
DNA Methylation-Independent Reversion of Gemcitabine Resist..:
Candelaria, Myrna
;
de la Cruz-Hernandez, Erick
;
Taja-Chayeb, Lucia
...
PLoS ONE. 7 (2012) 3 - p. e29181 , 2012
Link:
https://doi.org/10.1371/..
?
7
Epigenetic Therapy With Hydralazine and Magnesium Valproate..:
Cervera, Eduardo
;
Candelaria, Myrna
;
López-Navarro, Omar
...
Clinical Lymphoma Myeloma and Leukemia. 12 (2012) 3 - p. 207-212 , 2012
Link:
https://doi.org/10.1016/..
?
8
Acetylator status and N-acetyltransferase 2 gene polymorphi..:
Taja-Chayeb, Lucia
;
González-Fierro, Aurora
;
Miguez-Muñoz, Cristian
...
Pharmacogenetics and Genomics. 21 (2011) 12 - p. 894-901 , 2011
Link:
https://doi.org/10.1097/..
?
9
A double-blind, placebo-controlled, randomized phase III tr..:
Coronel, Jaime
;
Cetina, Lucely
;
Pacheco, Irlanda
...
Medical Oncology. 28 (2010) S1 - p. 540-546 , 2010
Link:
https://doi.org/10.1007/..
?
10
Hydralazine and magnesium valproate as epigenetic treatment..:
Candelaria, Myrna
;
Herrera, Aquileo
;
Labardini, Juan
...
Annals of Hematology. 90 (2010) 4 - p. 379-387 , 2010
Link:
https://doi.org/10.1007/..
?
11
The prince and the pauper. A tale of anticancer targeted ag..:
Dueñas-González, Alfonso
;
García-López, Patricia
;
Herrera, Luis
...
Molecular Cancer. 7 (2008) 1 - p. 82 , 2008
Link:
https://doi.org/10.1186/..
?
12
Weekly topotecan as second- or third-line treatment in pati..:
Coronel, Jaime
;
Cetina, Lucely
;
Candelaria, Myrna
...
Medical Oncology. 26 (2008) 2 - p. 210-214 , 2008
Link:
https://doi.org/10.1007/..
?
13
A phase II study of epigenetic therapy with hydralazine and..:
Candelaria, Myrna
;
Gallardo-Rincón, Dolores
;
Arce, Claudia
...
BMC Cancer. 7 (2007) S1 - p. , 2007
Link:
https://doi.org/10.1186/..
?
14
Epigenetic therapy with hydralazine and valproate associate..:
Candelaria, Myrna
;
Cetina, Lucely
;
Garcia, Alicia
...
BMC Cancer. 7 (2007) S1 - p. , 2007
Link:
https://doi.org/10.1186/..
?
15
A proof-of-principle study of epigenetic therapy with hydra..:
Arce, Claudia
;
Perez-Plasencia, Carlos
;
Gonzalez-Fierro, Aurora
...
BMC Cancer. 7 (2007) S1 - p. , 2007
Link:
https://doi.org/10.1186/..
1-15